Yigal Nochomovitz
Stock Analyst at Citi
(4.54)
# 1,033
Out of 5,014 analysts
812
Total ratings
45.4%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics | Reiterated: Buy | $40 → $43 | $16.91 | +154.29% | 23 | Sep 30, 2026 | |
| ZBIO Zenas BioPharma | Rated: Buy | $41 → $48 | $26.97 | +77.98% | 13 | Sep 30, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $145 → $160 | $85.48 | +87.18% | 4 | Sep 29, 2026 | |
| SNDX Syndax Pharmaceuticals | Reiterated: Buy | $57 | $18.80 | +203.19% | 19 | Sep 29, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $38 → $39 | $26.49 | +47.23% | 36 | Sep 29, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Sell | $13 | $18.22 | -28.65% | 14 | Sep 27, 2026 | |
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $40 → $33 | $20.15 | +63.77% | 10 | Sep 25, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Upgraded: Buy | $8 → $20 | $13.69 | +46.09% | 22 | Sep 24, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $390 → $397 | $312.37 | +27.09% | 6 | Sep 23, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $28 → $32 | $15.03 | +112.91% | 33 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $30.28 | +32.10% | 15 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $59 | $8.64 | +582.87% | 16 | Sep 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $38.42 | +69.18% | 20 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.1 | $1.88 | +65.33% | 34 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $7.23 | +93.64% | 8 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $20.19 | +73.35% | 5 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.27 | +419.88% | 5 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $9.91 | +111.91% | 2 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $25.83 | +74.22% | 31 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 | $55.32 | +59.07% | 27 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $249 → $253 | $141.84 | +78.37% | 12 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $17.12 | +75.23% | 2 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $1.27 | +529.92% | 23 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $3.84 | +160.42% | 15 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $6.82 | +163.93% | 14 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $3.42 | +221.64% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $21 | $7.74 | +171.49% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $1.33 | +426.32% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $453 → $466 | $365.94 | +27.34% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $83 | $48.15 | +72.38% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $85 | $58.88 | +44.36% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $45 | $26.34 | +70.84% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $378 → $386 | $332.56 | +16.07% | 12 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $10.44 | +149.04% | 9 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $17 → $16 | $13.47 | +18.78% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $9 | $14.91 | -39.64% | 5 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $25.94 | +61.91% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.66 | n/a | 7 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2 → $4 | $1.66 | n/a | 10 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $11 | $1.51 | n/a | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 → $8 | $1.21 | n/a | 8 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $10 | $0.0234 | n/a | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $14 | $3.86 | n/a | 16 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $1.2 | $2.49 | n/a | 18 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.37 | n/a | 11 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.23 | n/a | 16 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $35 → $10 | $8.50 | n/a | 17 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $8 | $1.63 | n/a | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.80 | n/a | 6 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.4 → $0.25 | $13.68 | n/a | 9 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $64.78 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $2 | $1.35 | n/a | 3 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €1.40 | n/a | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $8 | $45.84 | n/a | 5 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $11 | $9.93 | n/a | 24 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $2 | $1.12 | n/a | 5 | Aug 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9 | $0.92 | n/a | 1 | Mar 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 4 | Dec 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.00001 | n/a | 6 | Aug 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.05 | n/a | 2 | Apr 27, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $0.5028 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $7.67 | n/a | 6 | Mar 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $1.22 | n/a | 5 | Mar 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $1.44 | n/a | 1 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.31 | n/a | 3 | Nov 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,650.00 | n/a | 3 | Nov 21, 2014 |
Summit Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $40 → $43
Current: $16.91
Upside: +154.29%
Zenas BioPharma
Sep 30, 2026
Rated: Buy
Price Target: $41 → $48
Current: $26.97
Upside: +77.98%
Mirum Pharmaceuticals
Sep 29, 2026
Reiterated: Buy
Price Target: $145 → $160
Current: $85.48
Upside: +87.18%
Syndax Pharmaceuticals
Sep 29, 2026
Reiterated: Buy
Price Target: $57
Current: $18.80
Upside: +203.19%
Zymeworks
Sep 29, 2026
Reiterated: Buy
Price Target: $38 → $39
Current: $26.49
Upside: +47.23%
Sarepta Therapeutics
Sep 27, 2026
Reiterated: Sell
Price Target: $13
Current: $18.22
Upside: -28.65%
Acadia Pharmaceuticals
Sep 25, 2026
Reiterated: Buy
Price Target: $40 → $33
Current: $20.15
Upside: +63.77%
Arcturus Therapeutics Holdings
Sep 24, 2026
Upgraded: Buy
Price Target: $8 → $20
Current: $13.69
Upside: +46.09%
Ligand Pharmaceuticals
Sep 23, 2026
Reiterated: Buy
Price Target: $390 → $397
Current: $312.37
Upside: +27.09%
Ultragenyx Pharmaceutical
Sep 18, 2026
Reiterated: Buy
Price Target: $28 → $32
Current: $15.03
Upside: +112.91%
Sep 14, 2026
Reiterated: Buy
Price Target: $40
Current: $30.28
Upside: +32.10%
Sep 13, 2026
Reiterated: Buy
Price Target: $59
Current: $8.64
Upside: +582.87%
Sep 10, 2026
Reiterated: Buy
Price Target: $65
Current: $38.42
Upside: +69.18%
Sep 10, 2026
Reiterated: Buy
Price Target: $3.1
Current: $1.88
Upside: +65.33%
Sep 10, 2026
Reiterated: Buy
Price Target: $14
Current: $7.23
Upside: +93.64%
Sep 10, 2026
Reiterated: Buy
Price Target: $35
Current: $20.19
Upside: +73.35%
Sep 9, 2026
Reiterated: Buy
Price Target: $17
Current: $3.27
Upside: +419.88%
Sep 9, 2026
Reiterated: Buy
Price Target: $21
Current: $9.91
Upside: +111.91%
Sep 9, 2026
Reiterated: Buy
Price Target: $45
Current: $25.83
Upside: +74.22%
Sep 4, 2026
Reiterated: Buy
Price Target: $88
Current: $55.32
Upside: +59.07%
Sep 4, 2026
Reiterated: Buy
Price Target: $249 → $253
Current: $141.84
Upside: +78.37%
Sep 3, 2026
Reiterated: Buy
Price Target: $30
Current: $17.12
Upside: +75.23%
Aug 13, 2026
Rated: Buy
Price Target: $8
Current: $1.27
Upside: +529.92%
Aug 13, 2026
Reiterated: Buy
Price Target: $20 → $10
Current: $3.84
Upside: +160.42%
Aug 12, 2026
Reiterated: Buy
Price Target: $18
Current: $6.82
Upside: +163.93%
Aug 10, 2026
Reiterated: Buy
Price Target: $14 → $11
Current: $3.42
Upside: +221.64%
Aug 10, 2026
Reiterated: Buy
Price Target: $24 → $21
Current: $7.74
Upside: +171.49%
Aug 10, 2026
Rated: Buy
Price Target: $7
Current: $1.33
Upside: +426.32%
Aug 6, 2026
Rated: Buy
Price Target: $453 → $466
Current: $365.94
Upside: +27.34%
Aug 6, 2026
Reiterated: Buy
Price Target: $81 → $83
Current: $48.15
Upside: +72.38%
Aug 6, 2026
Reiterated: Buy
Price Target: $70 → $85
Current: $58.88
Upside: +44.36%
Aug 6, 2026
Reiterated: Buy
Price Target: $44 → $45
Current: $26.34
Upside: +70.84%
Aug 4, 2026
Reiterated: Buy
Price Target: $378 → $386
Current: $332.56
Upside: +16.07%
Jun 30, 2026
Reiterated: Buy
Price Target: $26
Current: $10.44
Upside: +149.04%
May 5, 2026
Rated: Buy
Price Target: $17 → $16
Current: $13.47
Upside: +18.78%
Mar 10, 2026
Rated: Buy
Price Target: $7 → $9
Current: $14.91
Upside: -39.64%
Mar 9, 2026
Reiterated: Buy
Price Target: $42
Current: $25.94
Upside: +61.91%
Sep 3, 2025
Reiterated: Buy
Price Target: $10
Current: $1.66
Upside: n/a
Mar 7, 2025
Upgraded: Buy
Price Target: $2 → $4
Current: $1.66
Upside: n/a
Dec 11, 2024
Reiterated: Buy
Price Target: $16 → $11
Current: $1.51
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: $11 → $8
Current: $1.21
Upside: n/a
Sep 12, 2024
Reiterated: Buy
Price Target: $12 → $10
Current: $0.0234
Upside: n/a
Aug 15, 2024
Reiterated: Buy
Price Target: $16 → $14
Current: $3.86
Upside: n/a
Jun 17, 2024
Reiterated: Hold
Price Target: $3.5 → $1.2
Current: $2.49
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $10
Current: $2.37
Upside: n/a
Dec 4, 2023
Reiterated: Buy
Price Target: $8
Current: $1.23
Upside: n/a
Nov 22, 2023
Reiterated: Sell
Price Target: $35 → $10
Current: $8.50
Upside: n/a
Sep 18, 2023
Reiterated: Buy
Price Target: $12 → $8
Current: $1.63
Upside: n/a
Sep 18, 2023
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.80
Upside: n/a
Aug 29, 2023
Reiterated: Hold
Price Target: $0.4 → $0.25
Current: $13.68
Upside: n/a
May 24, 2023
Rated: Buy
Price Target: $63
Current: $64.78
Upside: n/a
Nov 28, 2022
Reiterated: Buy
Price Target: $5 → $2
Current: $1.35
Upside: n/a
Sep 16, 2022
Reiterated: Buy
Price Target: €12.00
Current: €1.40
Upside: n/a
Apr 5, 2022
Downgraded: Hold
Price Target: $30 → $8
Current: $45.84
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $8 → $11
Current: $9.93
Upside: n/a
Aug 21, 2019
Downgraded: Sell
Price Target: $26 → $2
Current: $1.12
Upside: n/a
Mar 20, 2019
Initiated Coverage: Hold
Price Target: $9
Current: $0.92
Upside: n/a
Dec 29, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 13, 2015
Initiated Coverage: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Apr 27, 2015
Rated: Hold
Price Target: n/a
Current: $8.05
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $32
Current: $0.5028
Upside: n/a
Mar 30, 2015
Reiterated: Buy
Price Target: $49
Current: $7.67
Upside: n/a
Mar 16, 2015
Reiterated: Buy
Price Target: $53
Current: $1.22
Upside: n/a
Jan 9, 2015
Initiated Coverage: Buy
Price Target: $10
Current: $1.44
Upside: n/a
Nov 23, 2014
Rated: Hold
Price Target: n/a
Current: $12.31
Upside: n/a
Nov 21, 2014
Rated: Hold
Price Target: n/a
Current: $2,650.00
Upside: n/a